PVLA - Pieris Pharma Qarzning balans kapitallashuviga nisbati
0.09 metriki bilan aktiv qiymatini ko'rsatuvchi ushbu grafik Pieris Pharmaceuticals (PVLA) kompaniyasining joriy holati ko'rsatkichi bo'lib xizmat qiladi. Muvaffaqiyatsiz sinovlardan so'ng rahbariyat xarajatlarni minimallashtirmoqda, bunda tadqiqot va ishlanmalar (R&D) bo'limi molekulyar liniyani qayta ko'rib chiqib, ishlanmalarni cheklayotgan bir paytda patentlarni saqlab qolishga e'tibor qaratilmoqda. Biznes daromadlari onkologik va o'pka patologiyalariga qarshi kurashish uchun noyob protein texnologiyalaridan foydalanayotgan sog'liqni saqlash gigantlaridan olinadigan litsenziya to'lovlariga asoslangan.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_PVLA_-_Pieris-Pharmaceuticals_-_Debt-to-Net-Assets-Ratio "Pieris Pharmaceuticals - PVLA Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 28.10.2026) | 👁️GURU.Markets👁️")
Pieris Pharma (PVLA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning jamlanma tahliliyoti:Pieris Pharmaceuticals (PVLA)
Pieris Pharmaceuticals (PVLA) kompaniyasining xavfsizlik zaxirasini baholash umumiy majburiyatlarning kapitalga nisbati asosida amalga oshiriladi, bunda pastroq koeffitsient defolt xavfini minimallashtiradi, haddan tashqari yuqori koeffitsient esa kengayish imkoniyatlarini cheklaydi. Tarixiy qarzning kitob qiymatidagi kapitalizatsiya tendentsiyasini tahlil qilish orqali investor Anticalin platformasining moliyaviy barqarorligini aniqlashi mumkin, uning patent himoyasi va sog'liqni saqlash gigantlari bilan tuzilgan B2B shartnomalari innovatsiyalar ishlab chiqish jarayonida qarz yuklamasini samarali muvozanatlash imkonini beradi.
Pieris Pharmaceuticals kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Zenas Bio - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Immunome Corp|GOSS - Qarzlarning balans kapitallashuviga nisbati|KalVista Pharmaceuticals - Balans kapitallashuviga qarzlar|septerna.com (SEPN) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar SVRA (Savara)|Balans qiymatiga qarzlar RIGL|AnaptysBio Corp (ANAB) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Astria Corp (ATXS)|Balans kapitallashuviga qarzlar ENGN|RAPT Therapeutics Inc. - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati JBIO (Aerovate)|Aclaris Therapeutics Inc. (ACRS) - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati Kyverna KYTX|TLSA (Tiziana Life Sciences, Ltd.) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Cabaletta Bio, Inc. CABA|Qarzlarning balans kapitallashuviga nisbati ventyxbio.com|Theratechnologies (THTX) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Avalo Therapeutics, Inc. (AVTX)|Balans kapitallashuviga qarzlar ELDN (Eledon)|Agenus, Inc - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Climb Bio Inc (CLYM)|ZURA: Qarzning sof aktivlarga nisbati|ATYR (aTyr Pharma) - Qarzning balans kapitallashuviga nisbati|Adagene Inc. (ADAG) - Qarzning balans qiymatiga nisbati|IMA (ImageneBio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Shattuck Therapeutics|Balans kapitallashuviga qarzlar EQ (Equillium, Inc.)|Qarzning balans qiymatiga nisbati connectbiopharm.com (CNTB)|IMUX: Balans kapitallashuviga qarzlar|ATRA - Balans qiymatiga qarzlar|InflaRx GmbH - Qarzning balans qiymatiga nisbati|X4 Pharmaceuticals, Inc (XFOR) - Balans kapitallashuviga qarzlar|ACET - Qarzning balans qiymatiga nisbati|Celularity (CELU) - Qarzning balans kapitaliga nisbati|INMB: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Barinthus Biotherapeutics PLC|Balans kapitallashuviga qarzlar KZR (Kezar Life Sciences, Inc)|Qarzning balans qiymatiga nisbati SAB Biotherapeutics Inc (SABS)|Balans kapitallashuviga qarzlar AKTX (Akari Therapeutics)|Enlivex Therapeutics Ltd - Balans kapitallashuviga qarzlar|QTTB - Qarzning balans kapitallashuviga nisbati|GOVX: Qarzning balans kapitallashuviga nisbati|Edesa - Qarzning balans kapitallashuviga nisbati|IBIO (iBio Corporation) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Carisma Therapeutics Inc CARM|Qarzlarning balans kapitallashuviga nisbati xtlbio.com (XTLB)|Qarzning balans qiymatiga nisbati Bolt Biotherapeutics (BOLT)|Qarzning balans kapitallashuviga nisbati HCWB (hcwbiologics.com)|Qarzning balans kapitallashuviga nisbati Aptevo Therapeutics Inc. APVO|Qarzning balans kapitallashuviga nisbati AIM ImmunoTech, Inc. AIM|Aditxt Corp - Balans kapitallashuviga qarzlar|GRI: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati XORTX Therapeutics (XRTX)|Vyome Holdings Inc. (HIND) - Qarzlarning balans kapitallashuviga nisbati|REVB - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Indaptus Corp|Balans kapitallashuviga qarzlar SCNI|Balans kapitallashuviga qarzlar CALI (calcimedica.com)|Qarzning balans kapitallashuviga nisbati Affimed N.V.|Allakos Inc - Qarzning sof aktivlarga nisbati|HOOK: Qarzning balans kapitallashuviga nisbati|IGMS - Qarzning balans qiymatiga nisbati|ITOS: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar oceanbiomedical.com|TCBP - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Third Harmonic Bio Inc.